Literature DB >> 12353734

Bedside assessment of heel lance pain in the hospitalized infant.

Denise Harrison1, Cheryl Evans, Linda Johnston, Peter Loughnan.   

Abstract

OBJECTIVE: To evaluate a method of pain assessment to be used for hospitalized infants requiring blood test by a heel lance procedure.
DESIGN: Observational study evaluating pain measurement and interrater reliability of pain measurement in hospitalized infants.
SETTING: A Level III neonatal unit and a cardiac surgical unit at a major pediatric teaching hospital. PARTICIPANTS: 20 infants whose gestational age ranged from 28 weeks to full-term. MAIN OUTCOME MEASURES: Observations included behavioral measurements (facial expressions, body movements, and crying characteristics) and the physiologic measure of heart rate. Interrater reliability and the feasibility of using the procedural pain assessment method at the bedside were considered.
RESULTS: The three behavioral measurements and heart rate were responsive to the heel lance. Interrater reliability was high for facial expressions and crying scores but was low for body movements.
CONCLUSIONS: Modifications have been made to the method of procedural pain assessment to be used in a subsequent study. The modified method is expected to be a reliable measure of procedural pain caused by a heel lance and can easily be used at the bedside during the course of further research.

Entities:  

Mesh:

Year:  2002        PMID: 12353734     DOI: 10.1111/j.1552-6909.2002.tb00080.x

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  2 in total

1.  Cerebral hemodynamic changes during intensive care of preterm infants.

Authors:  Catherine Limperopoulos; Kimberlee K Gauvreau; Heather O'Leary; Marianne Moore; Haim Bassan; Eric C Eichenwald; Janet S Soul; Steven A Ringer; Donald N Di Salvo; Adré J du Plessis
Journal:  Pediatrics       Date:  2008-10-17       Impact factor: 7.124

Review 2.  Assessment and management of pain in infants.

Authors:  P J Mathew; J L Mathew
Journal:  Postgrad Med J       Date:  2003-08       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.